Kazuo Koyanagi

Isehara, 2591193, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 94 publications

Risk Factors for Mediastinal Lymph-Node Metastasis in Siewert Type I/II Esophagogastric Junction Cancers.

Risk Factors for Mediastinal Lymph-Node Metastasis in Siewert Type I/II Esophagogastric Junction Cancers.

Journal: Cancers

Published: June 03, 2026

Esophageal adenosquamous carcinoma with mucinous carcinoma-predominant lymph node metastases: a case report.

Esophageal adenosquamous carcinoma with mucinous carcinoma-predominant lymph node metastases: a case report.

Journal: General thoracic and cardiovascular surgery cases

Published: May 25, 2026

Clinical diagnostic accuracy and lymph node metastasis patterns in clinical T1bN0M0 esophageal squamous cell carcinoma: a supplementary analysis of JCOG1409.

Clinical diagnostic accuracy and lymph node metastasis patterns in clinical T1bN0M0 esophageal squamous cell carcinoma: a supplementary analysis of JCOG1409.

Journal: Esophagus : official journal of the Japan Esophageal Society

Published: March 30, 2026

Correlation Between Anastomotic Leakage and the Anastomotic Position of the Gastric Conduit After Esophagectomy Using ICG Fluorescence Imaging Stratification.

Correlation Between Anastomotic Leakage and the Anastomotic Position of the Gastric Conduit After Esophagectomy Using ICG Fluorescence Imaging Stratification.

Journal: World journal of surgery

Published: February 18, 2026

Inter-institutional heterogeneity in high-volume esophageal cancer centers: an ancillary study of JCOG1109 (JCOG2308A).

Inter-institutional heterogeneity in high-volume esophageal cancer centers: an ancillary study of JCOG1109 (JCOG2308A).

Journal: Esophagus : official journal of the Japan Esophageal Society

Published: December 24, 2025

Thoracic and cardiovascular surgeries in Japan during 2024 : Annual report by the Japanese Association for Thoracic Surgery.

Thoracic and cardiovascular surgeries in Japan during 2024 : Annual report by the Japanese Association for Thoracic Surgery.

Journal: General thoracic and cardiovascular surgery

Published: November 12, 2025

Optimal Timing of Surgery Following Neoadjuvant Therapy for Surgical and Oncological Outcomes in Advanced Esophageal Squamous Cell Carcinoma: An Exploratory Analysis of JCOG1109.

Optimal Timing of Surgery Following Neoadjuvant Therapy for Surgical and Oncological Outcomes in Advanced Esophageal Squamous Cell Carcinoma: An Exploratory Analysis of JCOG1109.

Journal: Annals of surgical oncology

Published: October 14, 2025

Relationship Between Hospital Volume and Outcomes of Minimally Invasive Esophagectomy for Esophageal Cancer: Analysis of the National Clinical Database in Japan.

Relationship Between Hospital Volume and Outcomes of Minimally Invasive Esophagectomy for Esophageal Cancer: Analysis of the National Clinical Database in Japan.

Journal: Annals of gastroenterological surgery

Published: September 26, 2025

Effects of β-hydroxy-β-methylbutyrate on skeletal muscle loss in a mouse model of esophageal squamous cell carcinoma.

Effects of β-hydroxy-β-methylbutyrate on skeletal muscle loss in a mouse model of esophageal squamous cell carcinoma.

Journal: Annals of translational medicine

Published: August 26, 2025

Prognostic Impact of Postoperative Complications After Neoadjuvant Therapy Followed by Esophagectomy for Esophageal Cancer: An Exploratory Analysis of Phase III Trial JCOG1109.

Prognostic Impact of Postoperative Complications After Neoadjuvant Therapy Followed by Esophagectomy for Esophageal Cancer: An Exploratory Analysis of Phase III Trial JCOG1109.

Journal: Annals of surgery

Published: July 07, 2025

Safety and efficacy of conversion therapy for metastatic esophageal cancer: exploratory analysis of JCOG1314.

Safety and efficacy of conversion therapy for metastatic esophageal cancer: exploratory analysis of JCOG1314.

Journal: Esophagus : official journal of the Japan Esophageal Society

Published: June 30, 2025

Postoperative immune-related adverse events after conversion surgery following induction immune checkpoint inhibitor-combined chemotherapy in patients with unresectable esophagogastric junction carcinoma: a report of two cases.

Postoperative immune-related adverse events after conversion surgery following induction immune checkpoint inhibitor-combined chemotherapy in patients with unresectable esophagogastric junction carcinoma: a report of two cases.

Journal: Journal of cardiothoracic surgery

Published: May 28, 2025

Showing 1-12 of 94

Last Updated: 09/26/2026